


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-18.90%
-0.63%
-28.17%
-5.97%
-5.15%
CAH
Cardinal Health
$227.26
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Pays a reliable dividend

Trading below its fair value
Risk Analysis

Investors losing their confidence
CAH Price Performance
$201.11 (+13.00%)
$204.81 (+10.96%)
$148.4 (+53.14%)
$127.55 (+78.17%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CAH Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CAH Street Sentiment is extremely bullish and have positive views on the near-term outlook
CAH has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 10, 2026
Upgrade
Buy
Citigroup
Dec 11, 2025
Initiate
Buy
Barclays
Dec 10, 2025
Initiate
Overweight
Barclays
Nov 06, 2025
Reiterate
Overweight
Wells Fargo
Nov 04, 2025
Reiterate
Buy
TD Cowen
What is CAH current stock price?
What are CAH stock strengths?
What is CAH Risk Level?
What is CAH market cap and volume?
What is CAH current Stock IQ?
Should I buy CAH stock right now?
Is CAH a Strong Buy right now?
What does a 'Strong Buy' rating mean for CAH?
What does a 'Strong Sell' rating mean for CAH?
What factors influence CAH's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-18.90%
-0.63%
-28.17%
-5.97%
-5.15%
CAH
Cardinal Health
Current Price
$227.26

CAH Price Performance
$201.11 (+13.00%)
$204.81 (+10.96%)
$148.4 (+53.14%)
$127.55 (+78.17%)
CAH Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CAH Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CAH Street Sentiment is extremely bullish and have positive views on the near-term outlook
CAH has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 10, 2026
Upgrade
Buy
Citigroup
Dec 11, 2025
Initiate
Buy
Barclays
Dec 10, 2025
Initiate
Overweight
Barclays
Nov 06, 2025
Reiterate
Overweight
Wells Fargo
Nov 04, 2025
Reiterate
Buy
TD Cowen
Nov 04, 2025
Reiterate
Outperform
Mizuho
CAH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Pays a reliable dividend

Trading below its fair value
Risk Analysis

Investors losing their confidence
CAH Latest Analysis
Cardinal Health beats top-line and bottom-line estimates. raises FY26 outlook.
Today
Cardinal Health surges following quarterly earnings beats guidance raise.
Today
Cardinal Health Q2 Earnings Report: What Investors Need to Know. The earnings results for CAH) for Q2 were made public on Thursday February 5 2026 at 06:45 AM.Here'.s a comprehensive overview of the announcement.Cardinal Health beat estimated earnings by 10.97% reporting an EPS of $2.63 versus an estimate of $2.37.Revenue was up $10.36 billion from the same period last year.Last quarter the company beat on EPS by $0.36 which was followed by a 0.49% increase ...
Today
Cardinal Health Inc Q2 Profit Increases Beats Estimates . (RTTNews) - Cardinal Health Inc (CAH) reported a profit for its second quarter that Increased from last year and beat the Street estimates.
Today
Pharma Specialty Units Likely to Drive Cardinal Healths Q2 Earnings. Cardinal Healths second-quarter earnings might have been driven by Pharma and Specialty Solutions as strong utilization and GLP-1 momentum must have raised revenues and EPS.
Wed Feb 4, 2026
Cardinal Health Inc. (CAH) Hits Fresh High: Is There Still Room to Run?. Cardinal (CAH) is at a 52-week high but can investors hope for more gains in the future? We take a look at the companys fundamentals for clues.
Tue Feb 3, 2026
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu Jan 29, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.